Form 8K Dyadic International Inc For: 30 March
- Investing.com
- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Dyadic International Inc (DYAI)
Track the Dyadic share price today and view real-time DYAI share price data, including charts, technicals, and key financials. View the DYAI premarket stock price ahead of the market session or assess the after hours quote. Explore DYAI stock price movements, trading volume, and market activity across the NASDAQ exchange.
What Is the Dyadic Stock Price Today?
The Dyadic stock price today is 0.866.
What Is the Stock Symbol for Dyadic?
The stock symbol for Dyadic is ""DYAI.""
What Stock Exchange Does Dyadic Trade On?
Dyadic is listed and trades on the NASDAQ stock exchange.
Is Dyadic a Good Stock to Buy?
Determining whether Dyadic or any stock is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the DYAI quote. (ISIN: US26745T1016)
What Is the Dyadic Stock Price Today?
The Dyadic stock price today is 0.866.
What Is the Stock Symbol for Dyadic?
The stock symbol for Dyadic is ""DYAI.""
What Stock Exchange Does Dyadic Trade On?
Dyadic is listed and trades on the NASDAQ stock exchange.
Is Dyadic a Good Stock to Buy?
Determining whether Dyadic or any stock is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the DYAI quote. (ISIN: US26745T1016)
NASDAQ
Currency in USD
0.866
+0.036(+4.34%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.835
0.931
52 wk Range
0.655
1.346
Earnings results expected in 14 days
1/2
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.8350.931
52 wk Range
0.6551.346
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
DYAI Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Neutral
Analysts Sentiment
Strong Buy
Price Target
7.000
Upside
+708.31%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Analysts do not anticipate the company will be profitable this year
- Form 8K Dyadic International Inc For: 6 March
- Investing.com
- Form 8K Dyadic International Inc For: 30 March
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Buy
Moving Averages
Strong Buy
Dyadic International, Inc., together with its subsidiaries, a biotechnology platform company, develops, produces, and sells industrial enzymes and other proteins in the United States and internationally. It utilizes the C1 platform in pharmaceutical applications, including the development and production of pharmaceutical products. The company offers Dapibus, a protein production platform that enable the rapid development and large-scale manufacture of cost-effective enzymes, proteins, metabolites, and other biologic products for life sciences, food and nutrition, and bio industrial applications. In addition, it develops DYAI-100, a C1-SARS-CoV-2 recombinant protein RBD vaccine candidate and first C1, which is in phase 1 clinical trial to produce protein tested in humans, and DYAI-100, a C1-produced COVID-19 vaccine candidate, which is in phase 1 clinical trials. The company has a research and development agreement with VTT Technical Research Centre of Finland, Ltd.; license agreement with South Africa’s Rubic One Health; and sub-license agreement with Abic Biological Laboratories Ltd., and Alphazyme, LLC. Dyadic International, Inc. was founded in 1979 and is headquartered in Jupiter, Florida.
Dyadic International Inc Earnings Call Summary for Q4/2025
- Q4 2025 revenue fell 11.7% to $3.09M as R&D collaboration declined, though grant revenue from Gates Foundation and CEPI partnerships increased.
- Operating loss widened to $7.19M from $5.9M in 2024; net loss reached $7.36M ($0.23/share) as company invests in commercialization transition.
- Cash position of $8.6M provides runway into 2027; ATM facility established for flexible capital access to support strategic initiatives.
- FY2026 revenue guidance set at $7.4M, driven by life sciences, food/nutrition, and bio-industrial segments as company shifts to commercial focus.
- Stock rose 3.32% to $0.845 post-earnings; analysts bullish with $5-$9 price targets despite 37% decline over past year.
Last Updated: 26/03/2026, 09:02 am
Read Full TranscriptCompare DYAI to Peers and Sector
Metrics to compare | DYAI | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipDYAIPeersSector | |
|---|---|---|---|---|
P/E Ratio | −4.2x | −1.3x | −0.5x | |
PEG Ratio | 0.30 | −0.34 | 0.00 | |
Price/Book | 25.1x | 4.0x | 2.6x | |
Price / LTM Sales | 10.0x | 45.2x | 3.2x | |
Upside (Analyst Target) | - | 46.8% | 45.2% | |
Fair Value Upside | Unlock | 4.3% | 6.4% | Unlock |
Analyst Ratings
1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 7.000
(+708.31% Upside)
Earnings
Latest Release
25/03/2026
EPS / Forecast
-0.04 / -0.04
Revenue / Forecast
564.35K / 1.44M
People Also Watch
FAQ
What Is the Dyadic (DYAI) Stock Price Today?
The Dyadic stock price today is 0.866 USD.
What Stock Exchange Does Dyadic Trade On?
Dyadic is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for Dyadic?
The stock symbol for Dyadic is "DYAI."
What Is the Dyadic Market Cap?
As of today, Dyadic market cap is 30.970M USD.
What Is Dyadic's Earnings Per Share (TTM)?
The Dyadic EPS (TTM) is -0.226.
When Is the Next Dyadic Earnings Date?
Dyadic will release its next earnings report on 07/05/2026.
From a Technical Analysis Perspective, Is DYAI a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.
How Many Times Has Dyadic Stock Split?
Dyadic has split 0 times.
How Many Employees Does Dyadic Have?
Dyadic has 6 employees.
What is the current trading status of Dyadic (DYAI)?
As of 23/04/2026, Dyadic (DYAI) is trading at a price of 0.866 USD, with a previous close of 0.830 USD. The stock has fluctuated within a day range of 0.835 USD to 0.931 USD, while its 52-week range spans from 0.655 USD to 1.346 USD.
What Is Dyadic (DYAI) Price Target According to Analysts?
The average 12-month price target for Dyadic is 7.000 USD, with a high estimate of 9 USD and a low estimate of 5 USD. 1 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +708.31% Upside potential.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.